Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
The restriction of viral receptors and coreceptors to the basolateral surface of airway epithelial cells has been blamed for the inefficient transfer of viral vectors to the apical surface of this tissue. We now report, however, that differentiated human airway epithelia internalize rAAV type-2 virus efficiently from their apical surfaces, despite the absence of known adeno-associated virus-2 (AAV-2) receptors or coreceptors at these sites. The dramatically lower transduction efficiency of rAAV infection from the apical surface of airway cells appears to result instead from differences in endosomal processing and nuclear trafficking of apically or basolaterally internalized virions. AAV capsid proteins are ubiquitinated after endocytosis, and gene transfer can be significantly enhanced by proteasome or ubiquitin ligase inhibitors. Tripeptide proteasome inhibitors increased persistent rAAV gene delivery from the apical surface >200-fold, to a level nearly equivalent to that achieved with basolateral infection. In vivo application of proteasome inhibitor in mouse lung augmented rAAV gene transfer from undetectable levels to a mean of 10.4 +/- 1.6% of the epithelial cells in large bronchioles. Proteasome inhibitors also increased rAAV-2-mediated gene transfer to the liver tenfold, but they did not affect transduction of skeletal or cardiac muscle. These findings suggest that tissue-specific ubiquitination of viral capsid proteins interferes with rAAV-2 transduction and provides new approaches to circumvent this barrier for gene therapy of diseases such as cystic fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro and preclinical animal studies have shown administration of bortezomib prevents degradation of internalized AAVs, reduces capsid presentation, and increases transduction efficiency by enhancing nuclear translocation of AAV [165, 224, 225].”
From Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer (2023) · cites this paper as [224]
In the citing paper
“After entry into cells, AAV cells can be ubiquitinated for degradation in proteasomes (91), generating increased amount of antigens for immune activation.”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [91]
In the citing paper
“AAV capsids undergo proteosome-mediated degradation in the cytoplasm, which may expose the packaged genomes to cytoplasmic DNA sensors.”
From Innate immune sensing of adeno-associated virus vectors (2024) · cites this paper as [43]
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524 · cited 1×
“Several specific, cellpermeable, peptide aldehyde inhibitors of proteasome pathways have recently been discovered (30, 31).”
BackgroundFenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 1×
“Several specific, cellpermeable, peptide aldehyde inhibitors of proteasome pathways have recently been discovered (30, 31).”
BackgroundSummerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406 · cited 1×
“Recently, the heparin sulfate proteoglycan receptor (3), and FGFR-1 (4) and αVβ5 integrin (5) coreceptors for AAV-2, have been localized to the basolateral membrane of polarized airway epithelial cells (6, 7).”
BackgroundMultiple proteolytic systems, including the proteasome, contribute to CFTR processing
Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L., & Riordan, J. R. (1995) · Cell · doi:10.1016/0092-8674(95)90241-4 · Cited by 897 · cited 18×
“A similar result was achieved when another ubiquitinproteasome pathway inhibitor, Z-LLL (33), was tested (data not shown).”
BackgroundInfluentialαVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 547 · cited 2×
“Alternative approaches have attempted to increase transgene expression by enhancing the molecular conversion of nonfunctional viral genomes to expressible forms, as in the case of rAAV (12, 13), or by increasing transcription and translation efficiency by altering the transgene expression cassettes (14).”
BackgroundDuan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522 · cited 2×
“It has been previously shown that AAV transduction in certain tissues such as muscle and retina is very efficient (16, 38), whereas other tissues including lung and liver are less favorably transduced (6, 39).”
BackgroundMethodSelf-citationThe Ubiquitin-Proteasome Pathway and Pathogenesis of Human Diseases
Schwartz, P., & Ciechanover, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.57 · Cited by 466 · cited 2×
“Regulated intracellular proteolysis through proteasomes plays a critical role in many physiological and pathological conditions (35).”
BackgroundSamulski, R. J., Chang, L. S., & Shenk, T. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449 · cited 1×
“The entire β-galactosidase expression cassette, including the RSV promoter, β-galactosidase reporter gene, and SV40 polyA signal, was excised by Sal I digestion and subsequently cloned into the pSub201 backbone by blunt-end ligation (18).”
MethodHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Bregman, D. B., Halaban, R., van Gool, A. J., Henning, K. A., Friedberg, E. C., & Warren, S. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11586 · Cited by 331 · cited 1×
“Ubiquitination significantly increased the molecular weight of capsid proteins (63, 73, and 87 kDa) to 220–250 kDa and is consistent with the size change after ubiquitination for other molecules (36).”
BackgroundWickham, T. J., Roelvink, P. W., Brough, D. E., & Kovesdi, I. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1570 · Cited by 326
Bartlett, J. S., Kleinschmidt, J., Boucher, R. C., & Samulski, R. J. (1999) · Nature Biotechnology · doi:10.1038/6185 · Cited by 230 · cited 1×
“These include manipulation of cell-surface receptors (9) and/or receptor ligands in the viral coat (10, 11).”
BackgroundAlexander, I. E., Russell, D. W., & Miller, A. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8282-8287.1994 · Cited by 222
Zabner, J., Freimuth, P., Puga, A., Fabrega, A., & Welsh, M. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119625 · Cited by 222 · cited 3×
“In the case of adenovirus, partitioning of viral receptors and coreceptors to basolateral surfaces has clearly been shown, at least in part, to contribute to low infectivity from the apical surface of the airway (2).”
BackgroundDNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors.
Russell, D. W., Alexander, I. E., & Miller, A. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5719 · Cited by 218 · cited 1×
“Several chemicals, including DNA-damaging agents (24), DNA synthesis and topoisomerase inhibitors (25), and cellular tyrosine kinases inhibitors (26, 27), have been shown to increase the AAV transduction efficiency in cultured primary fibroblasts and/or transformed cell lines.”
BackgroundReal-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction.
Bennett, J., Duan, D., Engelhardt, J. F., & Maguire, A. M. (1997) · PubMed · Cited by 204
Self-citationYang, J., Zhou, W., Zhang, Y., Zidon, T., Ritchie, T., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9468-9477.1999 · Cited by 201
Self-citationThe ubiquitin-proteasome system and endocytosis
Strous, G. J., & Govers, R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.10.1417 · Cited by 189
Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection
Duan, D., Li, Q., Kao, A. W., Yue, Y., Pessin, J. E., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10371-10376.1999 · Cited by 186 · cited 1×
“GFP3ori virions were metabolically labeled with [S35]methionine according to a protocol published previously (19).”
MethodSelf-citationDuan, D., Yue, Y., Yan, Z., McCray, P. B., & Engelhardt, J. F. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2761 · Cited by 171 · cited 10×
“At this time point, gene expression measured from an EGFP reporter was more than 200-fold higher in basolaterally infected cultures (data not shown) (6).”
BackgroundMethodInfluentialSelf-citationAdeno-Associated Virus as a Vector for Liver-Directed Gene Therapy
Xiao, W., Berta, S. C., Lu, M. M., Moscioni, A. D., Tazelaar, J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10222-10226.1998 · Cited by 166 · cited 1×
“It has been previously shown that AAV transduction in certain tissues such as muscle and retina is very efficient (16, 38), whereas other tissues including lung and liver are less favorably transduced (6, 39).”
BackgroundProteolysis: The proteasome: a protein-degrading organelle?
Rubin, D. M., & Finley, D. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00172-2 · Cited by 163 · cited 1×
“These inhibitors bind to the active sites of proteolytic enzymes within the proteasome core and reversibly block their function (32).”
Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1
Schwartz, O., Maréchal, V., Friguet, B., Arenzana-Seisdedos, F., & Heard, J.-M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3845-3850.1998 · Cited by 151 · cited 2×
“Proteasome systems are known to modulate the intracellular processing of many foreign and endogenous molecules, including viruses such as HIV (29).”
BackgroundHansen, J., Qing, K., Kwon, H.-J., Mah, C., & Srivastava, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.992-996.2000 · Cited by 147 · cited 1×
“In support of this notion, a recent report described impaired intracellular trafficking of viral particles to the nucleus in NIH 3T3 cells (41).”
BackgroundOdorizzi, G., Pearse, A., Domingo, D., Trowbridge, I. S., & Hopkins, C. R. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.1.139 · Cited by 133 · cited 1×
“Polarity is widely recognized to significantly influence endosomal processing of many proteins, and distinct sorting mechanisms have been described for the apical and basolateral compartments (40).”
BackgroundQing, K., Wang, X.-S., Kube, D. M., Ponnazhagan, S., Bajpai, A., & Srivastava, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10879 · Cited by 118 · cited 1×
“Several chemicals, including DNA-damaging agents (24), DNA synthesis and topoisomerase inhibitors (25), and cellular tyrosine kinases inhibitors (26, 27), have been shown to increase the AAV transduction efficiency in cultured primary fibroblasts and/or transformed cell lines.”
BackgroundA viral activator of gene expression functions via the ubiquitin–proteasome pathway
Everett, R. D., Orr, A., & Preston, C. M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7161 · Cited by 116 · cited 1×
“As has been found for type 1 herpes simplex virus (34), LLnL treatment had no significant effect on 4°C rAAV binding (Figure 6).”
MethodMah, C., Qing, K., Khuntirat, B., Ponnazhagan, S., Wang, X.-S., Kube, D. M., Yoder, M. C., & Srivastava, A. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9835-9843.1998 · Cited by 102 · cited 1×
“Several chemicals, including DNA-damaging agents (24), DNA synthesis and topoisomerase inhibitors (25), and cellular tyrosine kinases inhibitors (26, 27), have been shown to increase the AAV transduction efficiency in cultured primary fibroblasts and/or transformed cell lines.”
BackgroundNeurite Outgrowth in PC12 Cells
Obin, M., Mesco, E., Gong, X., Haas, A. L., Joseph, J., & Taylor, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11789 · Cited by 101
Wang, G., Davidson, B. L., Melchert, P., Slepushkin, V. A., van Es, H. H. G., Bodner, M., Jolly, D. J., & McCray, P. B. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9818-9826.1998 · Cited by 94
Duan, D., Sharma, P., Dudus, L., Zhang, Y., Sanlioglu, S., Yan, Z., Yue, Y., Ye, Y., Lester, R., Yang, J., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.161-169.1999 · Cited by 91 · cited 2×
“Consistent with our previous reports (13, 23), subsequent restriction enzyme mapping with Hirt DNA Southern blots confirmed this 2.”
BackgroundResultSelf-citationImmunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues.
Hughes, S., & Hall, P. A. (1993) · PubMed · Cited by 85
Teramoto, S., Bartlett, J. S., McCarty, D., Xiao, X., Samulski, R. J., & Boucher, R. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8904-8912.1998 · Cited by 73 · cited 1×
“Together with the fact that differentiated monolayers of airway cells are also resistant to AAV-2 infection (8), these studies suggest that aspects of either differentiation and/or polarity are responsible for reduced AAV infection from the apical surface.”
BackgroundDuan, D., Sehgal, A., Yao, J., & Engelhardt, J. F. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.6.2987 · Cited by 63 · cited 2×
“Alkaline phosphatase transgene expression was evaluated by histochemical staining in 15-μm frozen sections as described previously (20).”
MethodSelf-citationŞanlıoğlu, S., Benson, P. K., & Engelhardt, J. F. (2000) · Virology · doi:10.1006/viro.1999.0137 · Cited by 62 · cited 1×
“Our laboratory has also shown that rAAV can remain in an inactive state for as long as 7 days in confluent primary fibroblast cells until rescued by ultraviolet irradiation to a functionally active state (42).”
BackgroundSelf-citationSanlioglu, S., Duan, D., & Engelhardt, J. F. (1999) · Human Gene Therapy · doi:10.1089/10430349950018661 · Cited by 60 · cited 3×
“Consistent with our previous reports (13, 23), subsequent restriction enzyme mapping with Hirt DNA Southern blots confirmed this 2.”
BackgroundResultSelf-citationZabner, J., Wadsworth, S. C., Ae, S., & Welsh, M. J. (1996) · PubMed · Cited by 54
Structural and functional heterogeneity of integrated recombinant AAV genomes
Duan, D., Fisher, K. J., Burda, J. F., & Engelhardt, J. F. (1997) · Virus Research · doi:10.1016/s0168-1702(96)01425-6 · Cited by 45
Self-citationWalters, R. W., Duan, D., Engelhardt, J. F., & Welsh, M. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.535-540.2000 · Cited by 40 · cited 3×
“Given that hypotonic EGTA treatment alone only slightly increased persistence of AAV DNA (less than fourfold; Figure 9c, lane 11) or AAV-mediated gene expression (less than tenfold; Figure 5b) (6, 21) after apical infection, we reasoned that the predominant mechanism responsible for the combined effects of EGTA and LL…”
BackgroundMethodSelf-citationŞanlıoğlu, S., & Engelhardt, J. F. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300967 · Cited by 37 · cited 1×
“Because chemicals known to affect intranuclear events involved in rAAV transduction in other cell types (28) did not enhance rAAV apical infection in the airway, we sought instead to assess chemicals that might affect endocytic processing of internalized virions.”
BackgroundSelf-citationQing, K., Bachelot, T., Mukherjee, P., Wang, X.-S., Peng, L., Yöder, M. C., Leboulch, P., & Srivastava, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5663-5667.1997 · Cited by 21 · cited 1×
“These include manipulation of cell-surface receptors (9) and/or receptor ligands in the viral coat (10, 11).”
BackgroundWhiteway, A., Prentice, H. G., & Anderson, R. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950017888 · Cited by 9 · cited 3×
“First, we have provided conclusive evidence that the previously reported lack of known AAV-2 receptor and coreceptors (7) at the apical membrane of airway epithelia does not abrogate AAV infection.”
Background
Research works printed but not linked: 3
- Zabner, 1996, Gene Ther, 3, 458
- Hughes, 1993, Lab Invest, 69, 173
- Bennett, 1997, Invest Ophthalmol Vis Sci, 38, 2857
Cited by
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
“Coadministration of AAV2 with a proteosome inhibitor (449) results in improved transgene expression and augmented nuclear trafficking of the virus.”
BackgroundAdeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
“uitination of the intact virus can occur during transport to the nucleus [73].”
BackgroundAdeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 922
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Mingozzi, F., & High, K. A. (2013) · Blood · doi:10.1182/blood-2013-01-306647 · Cited by 955
“Early studies by Engelhardt and colleagues 89,90 showed that AAV vector particles are indeed ubiquitinated once internalized in the cytosol, a step that is fundamental for targeting intracellular proteins for degradation through More than 50% of humans develop anti-AAV humoral immunity after the…”
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
Metadata
- Authors
- Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Engelhardt, John F.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-06-01
- Volume
- 105
- Issue
- 11
- Pages
- 1573-1587
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC300848
- OpenAlex
- W1970138286
- Cited by
- 391
- References
- 45
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 8 · 2021: 5 · 2020: 9 · 2019: 17 · 2018: 6 · 2017: 9 · 2016: 4 · 2015: 11 · 2014: 10 · 2013: 18 · 2012: 18
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK54759)
- National Heart, Lung, and Blood Institute (R01HL058340)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK54759, P30DK054759)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- adeno-associated virus type 2, airway epithelium, endosomal processing, proteasome inhibitors, ubiquitin ligase inhibitors, nuclear trafficking, pulmonary gene therapy, cystic fibrosis
- MeSH terms
- Dependovirus, Animals, Bronchi, Capsid, Cells, Cultured, Cysteine Endopeptidases, Egtazic Acid, Epithelial Cells, Humans, Lung, Mice, Inbred BALB C, Multienzyme Complexes, Endosomes, Ubiquitins, Genetic Therapy, Cell Polarity, Gene Transfer Techniques, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.